Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linagliptin + Metformin QD vs Metformin BID in Treatment-Naive T2DM
NCT01438814Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2011
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 4 trial of linagliptin in type 2 diabetes mellitus (T2DM), sponsored by Boehringer Ingelheim. Started Nov 2011; status: completed.
02
Drugs
linagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01438814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01438814.